Dr. Yang Lin
- Founder/Chairman/Chief Scientific Officer, PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Dr. Lin Yang, Founder/Chairman/Chief Scientific Officer of PersonGen BioTherapeutics (Suzhou) Co., Ltd.; Distinguished Professor of Soochow University. He was an adjunct professor at MD Anderson Cancer Research Center, and has won many honors, including the Highest Honor in the National Disruptive Technology Innovation Contest Finals of the Ministry of Science and Technology of PRC. Dr. Yang has published more than 100 peer reviewed articles, including Cancer Cell, Cancer Research, Clinical Cancer Research, etc., and has been leading PersonGen team to develop a number of breakthrough first-in-class CART drugs, including the world’s first approved INDs of autologous CD7-CAR-T and B7-H3-CAR-T injections for T lymphocyte-derived malignancies and pediatric solid tumors, respectively. He also plays a critical role in building an internationally advanced industrialization base based on the fully automatic CART cell production process in China.